See more : Covestro AG (1COV.F) Income Statement Analysis – Financial Results
Complete financial analysis of Cloud DX Inc. (CDXFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cloud DX Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- AVVAA World Health Care Products, Inc. (AVVH) Income Statement Analysis – Financial Results
- COSMOS Pharmaceutical Corporation (3349.T) Income Statement Analysis – Financial Results
- Davangere Sugar Company Limited (DAVANGERE.NS) Income Statement Analysis – Financial Results
- Acri Capital Acquisition Corporation (ACAC) Income Statement Analysis – Financial Results
- Azure Minerals Limited (AZS.AX) Income Statement Analysis – Financial Results
Cloud DX Inc. (CDXFF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.clouddx.com
About Cloud DX Inc.
Cloud DX Inc. operates as a remote patient monitoring company. It offers Cloud DX Connected Health, an end-to-end virtual healthcare platform for monitoring patients with chronic illness, including chronic obstructive pulmonary disease and congestive heart failure, as well as patients recovering from surgery and COVID-19 patients outside hospitals. The company's Cloud DX Connected Health Kits includes its Cloud DX Bluetooth pulse oximeter, the Cloud DX wireless weight scale and optionally, a wireless Bluetooth blood pressure monitor, digital thermometer, and digital wireless glucose meter from 3rd party suppliers. It serves academic institutions, large hospitals, and provincial health authorities in Canada, as well as physician practices and hospitals in the United States. The company also offers VITALITI, a vital sign monitor for measuring electrocardiograph, heart rate, oxygen saturation, respiration, core body temperature, blood pressure, movement, steps, and posture. Cloud DX Inc. is headquartered in Brooklyn, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.81M | 1.17M | 782.30K | 1.16M | 1.25M | 247.77K |
| Cost of Revenue | 529.21K | 563.11K | 491.29K | 732.60K | 228.17K | 127.76K |
| Gross Profit | 1.28M | 602.90K | 291.01K | 431.20K | 1.02M | 120.01K |
| Gross Profit Ratio | 70.79% | 51.71% | 37.20% | 37.05% | 81.76% | 48.44% |
| Research & Development | 192.99K | 397.93K | 473.88K | 550.52K | 252.57K | 317.86K |
| General & Administrative | 6.90M | 9.11M | 9.34M | 5.97M | 842.16K | 1.08M |
| Selling & Marketing | 252.73K | 312.08K | 468.63K | 116.35K | 153.70K | 159.75K |
| SG&A | 7.15M | 9.43M | 9.80M | 6.08M | 287.20K | 6.44M |
| Other Expenses | 1.67M | -18.79K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 9.02M | 9.83M | 9.48M | 5.58M | 287.20K | 7.03M |
| Cost & Expenses | 9.55M | 10.39M | 9.97M | 6.31M | 287.20K | 7.16M |
| Interest Income | 0.00 | 1.60M | 709.40K | 732.23K | 336.99K | 224.11K |
| Interest Expense | 3.37M | 1.60M | 709.40K | 732.23K | 0.00 | 0.00 |
| Depreciation & Amortization | 477.96K | 498.77K | 407.95K | 340.14K | 164.51K | 168.72K |
| EBITDA | -6.93M | -8.79M | -10.24M | -4.74M | -4.40M | -6.82M |
| EBITDA Ratio | -382.42% | -748.52% | -1,122.64% | -412.98% | -22.96% | -2,751.18% |
| Operating Income | -7.74M | -9.72M | -10.42M | -6.55M | -287.20K | -6.99M |
| Operating Income Ratio | -426.90% | -833.54% | -1,332.04% | -562.81% | -22.96% | -2,819.27% |
| Total Other Income/Expenses | -3.04M | -1.17M | -934.58K | 737.73K | -4.68M | -146.18K |
| Income Before Tax | -10.78M | -10.89M | -11.36M | -5.81M | -312.20K | -7.13M |
| Income Before Tax Ratio | -594.93% | -934.04% | -1,451.51% | -499.42% | -24.95% | -2,878.27% |
| Income Tax Expense | -433.91K | -273.89K | -98.22K | 732.31K | -164.51K | 0.00 |
| Net Income | -10.35M | -10.62M | -11.26M | -5.81M | -312.20K | -7.13M |
| Net Income Ratio | -570.99% | -910.55% | -1,438.95% | -499.42% | -24.95% | -2,878.27% |
| EPS | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
| EPS Diluted | -0.11 | -0.15 | -0.18 | -0.67 | -0.27 | -5.39 |
| Weighted Avg Shares Out | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
| Weighted Avg Shares Out (Dil) | 93.13M | 72.09M | 64.28M | 8.73M | 1.14M | 1.32M |
Cloud DX expands contracts with two existing clients after its digital health platform Connected Health boosts remote patient monitoring programs
Cloud DX inks contract with palliative program to provide remote monitoring and health data platform
Cloud DX announces private placement financings to raise combined total of up to £5.5M
Cloud DX beats out US vendor in competitive RFQ for Ontario hospital contract
Cloud DX inks another contract extension with Ontario hospital
Cloud DX expands cardiac patient contract with Ontario hospital client
Cloud DX expands US footprint with addition of primary care clinic in Alaska
Cloud DX increases size of its non-brokered private placement of secured convertible debentures to up to $2.375M due to strong investor demand
Cloud DX sees 3Q revenue quadruple as commercial healthcare contracts stack up
Cloud DX welcomes former Medtronic Canada president Neil Fraser to its board
Source: https://incomestatements.info
Category: Stock Reports